[68Ga]Ga-DOTA PET for validation of spinal cerebrospinal fluid leakage in spontaneous intracranial hypotension

[68Ga]Ga-DOTA PET for validation of spinal cerebrospinal fluid leakage in spontaneous intracranial hypotension

Bibliographic Details
Main Authors:	P. Evangelou, M. Omrane, J. Thurow, M. Mix, C. Fung, N. Lützen, G. Blazhenets, H. Urbach, J. Beck, P. Meyer
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Brain and Spine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772529422004878

Similar Items

Inter- and intra-tumoral heterogeneity on [68Ga]Ga-DOTA-TATE/[68Ga]Ga-DOTA-TOC PET/CT predicts response to [177Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients
by: Camila Gadens Zamboni, et al.
Published: (2024-11-01)

Standardized image quality for 68Ga-DOTA-TATE PET/CT
by: Christina P. W. Cox, et al.
Published: (2020-03-01)

Preparation and biological studies of 68Ga-DOTA-alendronate
by: Ashraf Fakhari, et al.
Published: (2016-07-01)

Occupational radiation exposure assessment during the management of [68Ga]Ga-DOTA-TOC
by: Mercedes Riveira-Martin, et al.
Published: (2022-10-01)

Reduction of [68Ga]Ga-DOTA-TATE injected activity for digital PET/MR in comparison with analogue PET/CT
by: Christina P. W. Cox, et al.
Published: (2024-03-01)

Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
by: Anna Stenvall, et al.
Published: (2022-12-01)

Case report: Detecting giant cell arteritis in [68Ga]Ga-DOTA-Siglec-9-PET/CT
by: Simon M. Petzinna, et al.
Published: (2024-12-01)

The role of 68Ga-DOTA derivatives PET-CT in patients with ectopic ACTH syndrome
by: Filippo Ceccato, et al.
Published: (2020-04-01)

Microfluidic-based production of [68Ga]Ga-FAPI-46 and [68Ga]Ga-DOTA-TOC using the cassette-based iMiDEV™ microfluidic radiosynthesizer
by: Hemantha Mallapura, et al.
Published: (2023-12-01)

Monte Carlo investigation of PET [68Ga]Ga-DOTA-TOC activity-administration protocols for consistent image quality
by: Philip Kalaitzidis, et al.
Published: (2023-09-01)

Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG Uptake in Esophageal Cancer
by: Huipan Liu, et al.
Published: (2022-06-01)

Intraspinal Surgical Anatomy in Spontaneous Intracranial Hypotension
by: Christian Fung, et al.
Published: (2023-01-01)

Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression
by: Silvia Migliari, et al.
Published: (2023-02-01)

68GA-NOTA-UBI AND 68GA-DOTA-UBI AS RADIOPHARMACEUTICALS FOR THE DIAGNOSIS OF INFECTIOUS PROCESSES: PRECLINICAL STUDIES AND TRANSLATION TO CLINICAL APPLICATION
by: Ana Claudia Camargo Miranda, et al.
Published: (2024-04-01)

Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/MRI in the Preoperative Diagnosis of Gastric Cancer
by: Tao Du, et al.
Published: (2023-01-01)

Visualisation of in vivo protein synthesis during mycobacterial infection through [68Ga]Ga-DOTA-puromycin µPET/MRI
by: Sebastian Eigner, et al.
Published: (2024-08-01)

Noninvasive Monitoring of Early Cardiac Fibrosis in Diabetic Mice by [68Ga]Ga-DOTA-FAPI-04 PET/CT Imaging
by: Kaibin Lin, et al.
Published: (2024-04-01)

Same-day comparative protocol PET/CT-PET/MRI [68 Ga]Ga-DOTA-TOC in paragangliomas and pheochromocytomas: an approach to personalized medicine
by: Stefan Prado-Wohlwend, et al.
Published: (2023-01-01)

Prevalence of Brain Incidental Lesions Detected by <sup>68</sup>Ga-DOTA Peptides PET/CT
by: Domenico Albano, et al.
Published: (2022-07-01)

CYP3A4 inhibitors do not influence [68Ga]Ga-DOTA-TATE uptake in liver tissue
by: Youssef Chahid, et al.
Published: (2023-09-01)

Preparation, biological characterization and preliminary human imaging studies of 68Ga-DOTA-IBA
by: Yingwei Wang, et al.
Published: (2022-12-01)

Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
by: Thomas Franz Fassbender, et al.
Published: (2020-06-01)

Potential value of pre- and post-therapy [68Ga]Ga-DOTA-TATE PET/CT in the prognosis of response to PRRT in disseminated neuroendocrine tumors
by: Marta Opalińska, et al.
Published: (2022-08-01)

Evaluation of [<sup>68</sup>Ga]Ga-DOTA-AeK as a Potential Imaging Tool for PET Imaging of Cell Wall Synthesis in Bacterial Infections
by: Palesa C. Koatale, et al.
Published: (2024-08-01)

A systematic review of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT in the diagnostic value of malignant tumor bone metastasis
by: Lanying Li, et al.
Published: (2022-11-01)

Prospective comparison of 68Ga-DOTA-ibandronate and bone scans for detecting bone metastases in breast cancer
by: Feifan Xiang, et al.
Published: (2024-07-01)

Avaliação do SUVmax na captação do [68Ga]Ga-DOTA-TATE PET/CT em doentes com tumores neuroendócrinos: revisão de literatura
by: Carolina Maricato, et al.
Published: (2022-11-01)

Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers
by: Junhao Wu, et al.
Published: (2021-09-01)

On the Optimization of the Protocol for Automated Radiosyntheses of [68Ga]Ga-Pentixafor, [68Ga]Ga-FAPI-4 and [68Ga]Ga-DOTATATE in a Modular-Lab Standard
by: Sreeja Menon, et al.
Published: (2024-07-01)

Comparison of [18F]fluorodeoxyglucose and [68Ga]Gallium DOTA-TATE in patients with active giant cell arteritis
by: Alison H. Clifford, et al.
Published: (2025-03-01)

Tumour-to-liver ratio determined by [68Ga]Ga-DOTA-TOC PET/CT as a prognostic factor of lanreotide efficacy for patients with well-differentiated gastroenteropancreatic-neuroendocrine tumours
by: Yong-il Kim, et al.
Published: (2020-06-01)

Spinal Cerebrospinal Fluid Leakage in Spontaneous Intracranial Hypotension: An Intrathecal Gadolinium Enhanced MR-Myelography Study
by: Hakan Cebeci, et al.
Published: (2020-01-01)

Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of <sup>68</sup>Ga-PSMA and <sup>68</sup>Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients
by: Paola Mapelli, et al.
Published: (2021-11-01)

Comparison of [18F]DOPA and [68Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy
by: Emile B. Veenstra, et al.
Published: (2022-06-01)

[68Ga]Ga-DOTA-Siglec-9 Detects Pharmacodynamic Changes of FAP-Targeted IL2 Variant Immunotherapy in B16-FAP Melanoma Mice
by: Riikka Viitanen, et al.
Published: (2022-07-01)

Head-to-Head Comparison between [<sup>68</sup>Ga]Ga-DOTA.SA.FAPi and [<sup>18</sup>F]F-FDG PET/CT Imaging in Patients with Breast Cancer
by: Sanjana Ballal, et al.
Published: (2023-03-01)

Predictive value of 68[Ga]Ga-DOTA-TATE PET/CT volumetric parameters in assessing treatment response to long-acting somatostatin analogues in patients with well-differentiated neuroendocrine tumours
by: Karolina Morawiec-Sławek, et al.
Published: (2024-11-01)

Preparation and Evaluation of [<sup>18</sup>F]AlF-NOTA-NOC for PET Imaging of Neuroendocrine Tumors: Comparison to [<sup>68</sup>Ga]Ga-DOTA/NOTA-NOC
by: Johan Hygum Dam, et al.
Published: (2022-10-01)

Comparison of the relative diagnostic performance of 68Ga-DOTA-IBA and 18F-NaF for the detection of bone metastasis
by: Jia Deng, et al.
Published: (2024-03-01)

Synthesis and Radiolabelling of DOTA-Linked Glutamine Analogues with 67,68Ga as Markers for Increased Glutamine Metabolism in Tumour Cells
by: Ivan Greguric, et al.
Published: (2013-06-01)